Earnings

Axsome Therapeutics is entering a pivotal phase of commercial growth, with plans to significantly scale its operations and await a...

Despite posting quarterly results that smashed Wall Street's forecasts, Intuit finds itself navigating a complex landscape marked by sector-wide pressures...

Axon Enterprise's latest quarterly figures have significantly surpassed market forecasts, highlighting the company's accelerating growth trajectory. The provider of security...

Enovix Corporation reported fourth-quarter 2025 revenue that surpassed market expectations, yet investor sentiment remains decidedly cautious. The battery technology firm...

The ongoing corporate transformation at ams Osram continues to gain momentum, with a tightly interwoven strategy of asset sales, debt...

Investors in Deutsche Pfandbriefbank (PBB) faced a brutal reckoning as the German commercial property lender released its 2025 figures. The...

The investment case for Swiss pharmaceutical giant Roche presents a complex picture, marked by promising clinical developments in one area...

Investors have reacted with disappointment to Munich-based insurance giant Allianz's latest results, sending its stock lower. This negative market response...

Nvidia has once again posted financial results for the record books, surpassing nearly all analyst forecasts. However, the latest quarterly...

Investors are preparing to scrutinize BioNTech's upcoming annual report, viewing it as far more than a routine financial disclosure. The...